Kanamycin.
D003638:Deafness / Q000139:chemically induced*; D004342:Drug Hypersensitivity; D004352:Drug Resistance, Microbial; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D006801:Humans; D007612:Kanamycin / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D007668:Kidney / Q000378:metabolism; D007674:Kidney Diseases / Q000378:metabolism; D007709:Klebsiella / Q000187:drug effects; D009468:Neuromuscular Diseases / Q000139:chemically induced; D009925:Organ of Corti / Q000187:drug effects; D010243:Paralysis / Q000139:chemically induced; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D014376:Tuberculosis / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy; D000159:Vestibulocochlear Nerve / Q000187:drug effects
D007612:Kanamycin